首页> 外文期刊>Macromolecular bioscience >Targeted Delivery of Vaccine to Dendritic Cells by Chitosan Nanoparticles Conjugated with a Targeting Peptide Ligand Selected by Phage Display Technique
【24h】

Targeted Delivery of Vaccine to Dendritic Cells by Chitosan Nanoparticles Conjugated with a Targeting Peptide Ligand Selected by Phage Display Technique

机译:通过噬菌体展示技术选择的与靶向肽配体结合的壳聚糖纳米颗粒将疫苗靶向递送至树突状细胞

获取原文
获取原文并翻译 | 示例
       

摘要

The paper presents a novel dendritic cells (DC)-targeting peptide, TPAFRYS (TP) identified by phage display technique and conjugated to chitosan in order to develop an efficient DC-targeting vaccine delivery carrier. TP-conjugated chitosan nanoparticles (TPC-NPs) were prepared with ovalbumin (OVA) as a model vaccine by ionic gelation. Flow cytometry and immunocytochemistry studies demonstrated the higher targeting ability of TPC-NPs to DCs in compared to chitosan NPs. Moreover, TPC-NPs exhibited higher targeting specificity in DCs than macrophage and myoblasts. Furthermore, immunization of mice with OVA-loaded TPC-NPs enhanced OVA-specific serum IgG and IgG isotype antibodies production. Thus, DC-targeting strategy demonstrates a potential approach to enhance the effectiveness of vaccines.
机译:本文提出了一种新的靶向树突状细胞(DC)的肽,TPAFRYS(TP),通过噬菌体展示技术鉴定并与壳聚糖偶联,以开发一种有效的靶向DC的疫苗递送载体。用卵清蛋白(OVA)作为模型疫苗,通过离子凝胶法制备了结合有TP的壳聚糖纳米颗粒(TPC-NPs)。流式细胞仪和免疫细胞化学研究表明,与壳聚糖NP相比,TPC-NP对DC的靶向能力更高。而且,TPC-NP在DC中的靶向特异性高于巨噬细胞和成肌细胞。此外,用OVA负载的TPC-NP免疫小鼠可增强OVA特异性血清IgG和IgG同型抗体的产生。因此,DC靶向策略证明了增强疫苗效力的潜在方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号